WELLS FARGO & COMPANY/MN - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$169
-17.6%
268
+8.5%
0.00%
Q2 2023$205
+150.0%
247
+32.1%
0.00%
Q1 2023$82
-24.8%
187
+1.1%
0.00%
Q4 2022$109185
+2.8%
0.00%
Q3 2022$0180
+7.8%
0.00%
Q2 2022$01670.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders